BV-27

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameBV-27

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionNeoplasm antigens modulatorsLaminin receptors modulators

TargetsLaminin receptorsNeoplasm antigens

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBenovus Bio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBenovus Bio Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A